These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30451169)

  • 21. Optical coherence tomography angiography in central serous chorioretinopathy: The current clinical role and future perspectives.
    Pujari A; Surve A; Azad SV; Beniwal A; Sj V; Chawla R; Sachan A; Kumar A; Kumar A
    Surv Ophthalmol; 2022; 67(1):68-82. PubMed ID: 34000252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy.
    Mattingly JJ; Amram AL; El-Annan J
    Can J Ophthalmol; 2018 Oct; 53(5):e182-e183. PubMed ID: 30340736
    [No Abstract]   [Full Text] [Related]  

  • 23. Central serous chorioretinopathy following medial transposition of split lateral rectus muscle for complete oculomotor nerve palsy.
    Sorenson R; Soni A
    J AAPOS; 2017 Apr; 21(2):161-162. PubMed ID: 28017901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current role of optical coherence tomography angiography: Expert panel discussion.
    Agarwal A; Grewal DS; Jaffe GJ; Stewart MW; Srivastava S; Gupta V
    Indian J Ophthalmol; 2018 Dec; 66(12):1696-1699. PubMed ID: 30451168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic central serous chorioretinopathy.
    Hanumunthadu D; Tan ACS; Singh SR; Sahu NK; Chhablani J
    Indian J Ophthalmol; 2018 Dec; 66(12):1704-1714. PubMed ID: 30451170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
    Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B
    Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N
    Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of central serous choroidopathy: A novel hypothesis.
    Chawla R
    Indian J Ophthalmol; 2024 Oct; 72(10):1387-1389. PubMed ID: 39331425
    [No Abstract]   [Full Text] [Related]  

  • 30. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.
    Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy.
    Parameswarappa DC; Arora S; Singh SR; Sahoo NK; Maltsev DS; Kulikov AN; Iovino C; Tatti F; Venkatesh R; Zaheer H; Reddy NG; Pulipaka RS; Peiretti E; Chhablani J
    Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1147-1152. PubMed ID: 34633519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASSOCIATION OF OBSTRUCTIVE SLEEP APNEA WITH CENTRAL SEROUS CHORIORETINOPATHY AND CHOROIDAL THICKNESS: A Systematic Review and Meta-Analysis.
    Wu CY; Riangwiwat T; Rattanawong P; Nesmith BLW; Deobhakta A
    Retina; 2018 Sep; 38(9):1642-1651. PubMed ID: 29474303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

  • 34. Loculation of Fluid in the Posterior Choroid in Eyes With Central Serous Chorioretinopathy.
    Takkar B; Azad S; Sodhi PS
    Am J Ophthalmol; 2016 Mar; 163():194-195. PubMed ID: 26775252
    [No Abstract]   [Full Text] [Related]  

  • 35. Multimodal Imaging-Based Central Serous Chorioretinopathy Classification.
    Chhablani J; Cohen FB;
    Ophthalmol Retina; 2020 Nov; 4(11):1043-1046. PubMed ID: 33131671
    [No Abstract]   [Full Text] [Related]  

  • 36. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
    Teussink MM; Breukink MB; van Grinsven MJ; Hoyng CB; Klevering BJ; Boon CJ; de Jong EK; Theelen T
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5229-37. PubMed ID: 26244299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH STEROID ENEMA.
    Peiris TJ; El Rami HE; Sun JK
    Retin Cases Brief Rep; 2021 Jan; 15(1):15-17. PubMed ID: 30063579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
    Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
    Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A; Daruich A; Zola M; Behar-Cohen F
    Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of central serous chorioretinopathy multimodal imaging-based classification system.
    Chhablani J; Behar-Cohen F;
    Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1161-1169. PubMed ID: 34669028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.